Frequently Bought Together
HNC2440 is an ionizable lipid designed for lipid nanoparticle (LNP) assembly in nucleic acid delivery. It can bind negatively charged RNA and co-assemble with phospholipids, cholesterol, and PEG lipids to form LNPs. Following cellular uptake via endocytosis, the RNA-LNP complex escapes the endosome and releases its cargo. The liberated mRNA is subsequently translated into protein by ribosomes. HNC2440 exhibits high delivery efficiency and rapid clearance.
Specifications
|
Product Name |
Ionizable Lipid HNC2440 |
|
Molecular Formula |
C46H89NO4 |
|
Molecular Weight |
720.22 |
|
CAS No. |
NA |
|
Purity |
HPLC ≥97% |
Components
|
Components No. |
Name |
40890ES01 |
40890ES03 |
|
40890 |
Ionizable Lipid HNC2440 |
100 mg |
1 g |
Instructions
For the in vitro and in vivo studies, LNPs were formulated at a molar ratio of HNC2440 : cholesterol : DSPC : DMG-PEG2k = 48.5 : 38.9 : 11.1 : 1.5 with an N/P ratio of 4.84, and encapsulated using a microfluidic mixing process.
Figures
1. Efficient mRNA Delivery

Figure 1. Delivery efficiency of Fluc mRNA LNP and Gluc mRNA LNP prepared with HNC2440 in mice
HNC2440 enables efficient mRNA delivery in mice, as demonstrated by Fluc mRNA-LNP (left) and Gluc mRNA-LNP (right), with performance comparable to LNPs prepared with a clinically used ionizable lipid.
2. Fast Clearance Profile

Figure 2. Residual ionizable lipid in the liver and spleen after intravenous administration of Fluc mRNA LNP
HNC2440 exhibits significantly faster metabolism and elimination in liver and spleen compared with a clinically used ionizable lipid following a single intravenous administration of mRNA-LNP at 0.1 mg/kg in mice.
Storage
FAQ
Citations
Applications
Misschien vind je het ook leuk
Navraag
FAQ
Het product is alleen bedoeld voor onderzoeksdoeleinden en is niet bedoeld voor therapeutisch of diagnostisch gebruik bij mensen of dieren. Producten en inhoud worden beschermd door patenten, handelsmerken en auteursrechten die eigendom zijn van
Voor bepaalde toepassingen zijn mogelijk aanvullende intellectuele eigendomsrechten van derden vereist.

